CRISPR THERAPEUTICS AG — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+1.0% +$23M
$2.27B
Current Assets↑+2.5% +$49M
$1.99B
Cash & Equivalents↑+16.5% +$49M
$348M
ST Investments↑+1.4% +$23M
$1.63B
Receivables↓-100.0% -$25M
$0
Net PPE↓-13.6% -$18M
$116M
Intangibles
$0
Total Liabilities↑+10.8% +$33M
$343M
Current Liabilities↑+69.9% +$61M
$149M
Account Payables↓-24.3% -$4M
$11M
Stockholders Equity↓-0.5% -$10M
$1.92B
Retained Earnings↓-42.6% -$582M
$-1.95B
Operating Lease ROU Asset↓-8.2% -$12M
$132M
Operating Lease Liability↓-7.6% -$17M
$207M
Gross PP&E↑+0.3% +$538K
$207M
Accumulated Depreciation↑+26.0% +$19M
$91M
Contract Asset
—
Contract Liability↑+28.2% +$3M
$16M
Contract Liability (Current)↑+310.2% +$12M
$16M
Contract Liability (Noncurrent)↓-100.0% -$12M
$0